Interaction and compatibility studies in the development of olmesartan medoxomil and hydrochlorothiazide formulations under a real manufacturing process
Date
2022
Contributors
relationships.isEditorOf
Journal Title
Journal ISSN
Volume Title
Publisher
MDPI
item.page.series
item.page.source
Pharmaceutics 2022, vol.14(2), p.424
item.page.relation
https://doi.org/10.3390/pharmaceutics14020424
Abstract
Description
Keywords
AGENTES HIPOTENSORES, MEDICAMENTOS, INTERACCIONES DE MEDICAMENTOS